Intervention on Socio-emotional Development and Well-being Through ICTs in Early Adulthood (EMOWELL)

April 29, 2026 updated by: Inmaculada Montoya Castilla, University of Valencia

Intervention Through an Intelligent Technological Platform for Social-emotional Development and the Promotion of Well-being in Adolescence and Early Adulthood

emoWELL is a serious game, that is, a video game designed to inform and train in skills and competencies in a more dynamic way. emoWELL focuses on understanding and developing healthy emotional regulation strategies to improve well-being.

Study Overview

Detailed Description

Computer-based videogame. The program has a graphic adventure format, where the player controls an avatar who embarks on a train journey. Throughout this journey, the train will make five different stops where the player will learn about emotional regulation through activities or puzzles, readings and different interventions with the game's characters. At the first stop, the player will receive psychoeducation about emotional regulation and the most frequent adaptive and maladaptive regulation strategies. In the next three areas, exercises will be carried out to apply these strategies on variables such as self-esteem, self-care, stress, time management and social support. Finally, in the last area, the player will review the different contents learned. In addition to the train and the five stops or areas described, the game includes the area of the avatar's house and a final scenario that will vary depending on the player's answers throughout the adventure, in order to highlight the most important learning and conclude the game. Therefore, emoWELL consists of 8 areas in total.

The intervention is carried out autonomously. In addition to the computer game, emoWELL is linked to a mobile application so that the user can practice, integrate and reinforce the knowledge learned in the remote game, being both platforms indispensable in the intervention.

Study Type

Interventional

Enrollment (Actual)

385

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Valencian Comunity
      • Valencia, Valencian Comunity, Spain, 46020
        • Spain

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • To have signed the informed consent (or their legal tutors).
  • Being between 18 and 29 years old.

Exclusion Criteria:

  • Inability to understand the activities or the language used.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental: Intervention group
(1) Participants who meet the inclusion criteria will be contacted. (2) Participants will answer the questionnaire battery (T1) (3) Participants will participate in the intervention by remotely playing the EMOWELL desktop serious game and the EMOWELL app. (4) They will answer the T2 questionnaires.
No Intervention: No Intervention: Control group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Inventory of the Dimensions of Emerging Adulthood (IDEA-S)
Time Frame: Time 1 (first month)
The Spanish version is composed of 31 items. It is answered using a Likert scale from 1 (strongly disagree) to 3 (strongly agree). A higher score on a scale means a greater presence of these categories in the stage. It assesses the different characteristics of emerging adulthood: identity exploration, experimentation/possibilities, negativity/instability, other-centered, self-centered, feeling in between.
Time 1 (first month)
Inventory of the Dimensions of Emerging Adulthood (IDEA-S)
Time Frame: Time 2 (4th month)
The Spanish version is composed of 31 items. It is answered using a Likert scale from 1 (strongly disagree) to 3 (strongly agree). A higher score on a scale means a greater presence of these categories in the stage. It assesses the different characteristics of emerging adulthood: identity exploration, experimentation/possibilities, negativity/instability, other-centered, self-centered, feeling in between.
Time 2 (4th month)
Difficulties in Emotion Regulation Scale (DERS)
Time Frame: Time 1 (first month)
The Spanish version is composed of 28 items. It is answered using a Likert scale from 1 (hardly ever) to 5 (almost always). This scale assesses difficulties associated of the emotion regulation process: emotional lack of control, life interference, lack of emotional attention, emotional confusion, and emotional rejection. Therefore, a higher score within each scale signals more difficulties in emotional regulation.
Time 1 (first month)
Difficulties in Emotion Regulation Scale (DERS)
Time Frame: Time 2 (4th month)
The Spanish version is composed of 28 items. It is answered using a Likert scale from 1 (hardly ever) to 5 (almost always). This scale assesses difficulties associated of the emotion regulation process: emotional lack of control, life interference, lack of emotional attention, emotional confusion, and emotional rejection. Therefore, a higher score within each scale signals more difficulties in emotional regulation.
Time 2 (4th month)
Cognitive Emotion Regulation Questionnaire (CERQ-18)
Time Frame: Time 1 (first month)
The instrument assesses cognitive strategies for emotional regulation. The version of the instrument used consists of 18 items and has five polytomous response options ranging from almost never (1) to always (5). The items are grouped into nine strategies: Rumination, Catastrophizing, Self-blaming, Blaming others, Putting in perspective, Acceptance, Positive focus, Positive reinterpretation, and Refocusing on plans; at a rate of two items per strategy.
Time 1 (first month)
Cognitive Emotion Regulation Questionnaire (CERQ-18)
Time Frame: Time 2 (4th month)
The instrument assesses cognitive strategies for emotional regulation. The version of the instrument used consists of 18 items and has five polytomous response options ranging from almost never (1) to always (5). The items are grouped into nine strategies: Rumination, Catastrophizing, Self-blaming, Blaming others, Putting in perspective, Acceptance, Positive focus, Positive reinterpretation, and Refocusing on plans; at a rate of two items per strategy.
Time 2 (4th month)
Psychological Well-Being Scales (PWBS)
Time Frame: Time 2 (4th month)

The Spanish version is composed of 39 items. It is answered using a Likert scale from 1 (totally agree) to 6 (totally disagree).

A higher score on each scale indicates higher levels in the resulting dimensions of psychological well-being:

Self-acceptance, Positive relationships, Autonomy, Environmental mastery, Purpose in life and Personal growth.

Time 2 (4th month)
Emotion Regulation Questionnaire (ERQ)
Time Frame: Time 1 (first month)
The scale is composed by 10 items. It is answered using a 7-point Likert scale.
Time 1 (first month)
Emotion Regulation Questionnaire (ERQ)
Time Frame: Time 2 (4th month)
The scale is composed by 10 items. It is answered using a 7-point Likert scale.
Time 2 (4th month)
Psychological Well-Being Scales (PWBS)
Time Frame: Time 1 (first month)

The Spanish version is composed of 29 items. It is answered using a Likert scale from 1 (totally agree) to 6 (totally disagree).

A higher score on each scale indicates higher levels in the resulting dimensions of psychological well-being:

Self-acceptance, Positive relationships, Autonomy, Environmental mastery, Purpose in life and Personal growth.

Time 1 (first month)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rosenberg Self-Esteem Scale (RSE)
Time Frame: Time 1 (first month)
The RSE is an unidimensional instrument that consists of 10 items that assess self-esteem. Participants are asked to respond to each item using a four-point Likert scale ranging from "Strongly Disagree" to "Strongly Agree." A higher score indicates higher levels of self-esteem.
Time 1 (first month)
Rosenberg Self-Esteem Scale (RSE)
Time Frame: Time 2 (4th month)
The RSE is an unidimensional instrument that consists of 10 items that assess self-esteem. Participants are asked to respond to each item using a four-point Likert scale ranging from "Strongly Disagree" to "Strongly Agree." A higher score indicates higher levels of self-esteem.
Time 2 (4th month)
Brief Symptom Inventory (BSI-18)
Time Frame: Time 1 (first month)
The instrument evaluates psychological distress, collected in three dimensions: anxiety, depression and somatization. It is composed of 18 items answered on a likert scale from 0 (Not at all) to 4 (Very much). Higher levels on each of these scales imply higher levels of anxiety, depression or somatization, respectively.
Time 1 (first month)
Brief Symptom Inventory (BSI-18)
Time Frame: Time 2 (4th month)
The instrument evaluates psychological distress, collected in three dimensions: anxiety, depression and somatization. It is composed of 18 items answered on a likert scale from 0 (Not at all) to 4 (Very much). Higher levels on each of these scales imply higher levels of anxiety, depression or somatization, respectively.
Time 2 (4th month)
Three-item loneliness scale (TILS)
Time Frame: Time 1 (first month)
This scale evaluates the perception of loneliness. It is composed of three items answered on a Likert scale from 0 (Almost never) to 2 (Frequently). The higher the score, the greater the perception of loneliness.
Time 1 (first month)
Three-item loneliness scale (TILS)
Time Frame: Time 2 (4th month)
This scale evaluates the perception of loneliness. It is composed of three items answered on a Likert scale from 0 (Almost never) to 2 (Frequently). The higher the score, the greater the perception of loneliness.
Time 2 (4th month)
''Optimism questionnaire'' (COP)
Time Frame: Time 1 (first month)
The last instrument presented is composed of 9 items. It evaluates the optimism of the participants. It is answered on a Likert scale from 1 to 5. A higher score implies higher levels of optimism.
Time 1 (first month)
''Optimism questionnaire'' (COP)
Time Frame: Time 2 (4th month)
The last instrument presented is composed of 9 items. It evaluates the optimism of the participants. It is answered on a Likert scale from 1 to 5. A higher score implies higher levels of optimism.
Time 2 (4th month)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2021

Primary Completion (Actual)

August 31, 2024

Study Completion (Actual)

August 31, 2025

Study Registration Dates

First Submitted

June 14, 2023

First Submitted That Met QC Criteria

September 19, 2023

First Posted (Actual)

September 22, 2023

Study Record Updates

Last Update Posted (Actual)

April 30, 2026

Last Update Submitted That Met QC Criteria

April 29, 2026

Last Verified

June 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Emotion Regulation

Subscribe